Stock listing

ATNM Stock Price, News, Filings & Events — Actinium Pharmaceuticals, Inc. (delaware)

Selected listing: ATNM · BOATS · USD · US

This page tracks Actinium Pharmaceuticals, Inc. (delaware)'s ATNM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATNM:BOATS. ATNM:BOATS is the stock-level entry point for investors researching Actinium Pharmaceuticals, Inc. (delaware), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinium Pharmaceuticals, Inc. is a public company based in Delaware, trading under the ticker ATNM. The company operates in the American market and has a market capitalization of approximately $28.9 million. Actinium focuses on developing innovative therapies for cancer treatment.

ATNM:BOATSUSDUSUpdated September 12, 2026
Actinium Pharmaceuticals, Inc. (delaware) logo
Ticker
ATNM:BOATS
Asset type
Stock
Market cap
$44.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Actinium Pharmaceuticals, Inc. (delaware) ATNM:BOATS stock context

This page tracks Actinium Pharmaceuticals, Inc. (delaware)'s ATNM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATNM:BOATS. ATNM:BOATS is the stock-level entry point for investors researching Actinium Pharmaceuticals, Inc. (delaware), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Actinium Pharmaceuticals, Inc. is a public company based in Delaware, trading under the ticker ATNM. The company operates in the American market and has a market capitalization of approximately $28.9 million. Actinium focuses on developing innovative therapies for cancer treatment.

Latest news from Actinium Pharmaceuticals, Inc. (delaware)

All Actinium Pharmaceuticals, Inc. (delaware) news →

Research Actinium Pharmaceuticals, Inc. (delaware)

Alternate listings